DK108985C - Fremgangsmåde til fremstilling af mæslingevaccine indeholdende levende, svækket mæslingevirus. - Google Patents

Fremgangsmåde til fremstilling af mæslingevaccine indeholdende levende, svækket mæslingevirus.

Info

Publication number
DK108985C
DK108985C DK536963AA DK536963A DK108985C DK 108985 C DK108985 C DK 108985C DK 536963A A DK536963A A DK 536963AA DK 536963 A DK536963 A DK 536963A DK 108985 C DK108985 C DK 108985C
Authority
DK
Denmark
Prior art keywords
measles
producing
vaccine containing
containing live
attenuated
Prior art date
Application number
DK536963AA
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK108985C publication Critical patent/DK108985C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK536963AA 1961-09-08 1962-09-07 Fremgangsmåde til fremstilling af mæslingevaccine indeholdende levende, svækket mæslingevirus. DK108985C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB32421/61A GB960850A (en) 1961-09-08 1961-09-08 Measles virus vaccine

Publications (1)

Publication Number Publication Date
DK108985C true DK108985C (da) 1968-03-04

Family

ID=10338339

Family Applications (1)

Application Number Title Priority Date Filing Date
DK536963AA DK108985C (da) 1961-09-08 1962-09-07 Fremgangsmåde til fremstilling af mæslingevaccine indeholdende levende, svækket mæslingevirus.

Country Status (9)

Country Link
US (1) US3214340A (da)
AT (1) AT242294B (da)
BR (1) BR6242772D0 (da)
CA (1) CA937863A (da)
CH (1) CH414061A (da)
DK (1) DK108985C (da)
FR (1) FR2699M (da)
GB (1) GB960850A (da)
SE (1) SE332685B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846543A (en) * 1963-01-02 1974-11-05 Monsanto Co Process for the separation of virus from non-viral proteins
US4374201A (en) * 1965-07-09 1983-02-15 The United States Of America As Represented By The Secretary Of The Army Process for coating a dry variola virus
US4380582A (en) * 1965-07-09 1983-04-19 The United States Of America As Represented By The Secretary Of The Army Preparation of dry variola virus
GB1218277A (en) * 1968-08-20 1971-01-06 Miles Lab Dry water-dispersible aluminium hydroxide gels
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
US4211843A (en) * 1977-11-30 1980-07-08 L'institut Armand-Frappier Strain of measles virus and process of producing the same
NL191729C (nl) * 1978-04-12 1996-05-03 Merck & Co Inc Gestabiliseerd vaccin.
DE2816349A1 (de) * 1978-04-14 1979-10-25 Merck & Co Inc Vaccinstabilisator
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
GB8609623D0 (en) * 1986-04-19 1986-05-21 Buckburn Ltd Storing intracellular parasites
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
CN102406933A (zh) * 2011-11-25 2012-04-11 成都康华生物制品有限公司 一种麻疹减毒活疫苗的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879202A (en) * 1954-11-05 1959-03-24 American Cyanamid Co Stabilization of live viral vaccines by hexahydric alcohols
US3133861A (en) * 1961-11-08 1964-05-19 Dow Chemical Co Attenuated live measles virus vaccine and method of production

Also Published As

Publication number Publication date
US3214340A (en) 1965-10-26
FR2699M (da) 1964-08-03
SE332685B (da) 1971-02-15
BR6242772D0 (pt) 1973-05-24
GB960850A (en) 1964-06-17
CA937863A (en) 1973-12-04
CH414061A (de) 1966-05-31
AT242294B (de) 1965-09-10

Similar Documents

Publication Publication Date Title
DK108985C (da) Fremgangsmåde til fremstilling af mæslingevaccine indeholdende levende, svækket mæslingevirus.
DK117316B (da) Fremgangsmåde til fremstilling af mono- eller polyfunktionelle vacciner mod human-, heste-, svine- eller fugleinfluenzavirus.
DK121316B (da) Fremgangsmåde til afsvækkelse af levende mæslingevirus.
DK104193C (da) Fremgangsmåde til stabilisering af labile, antigene virusmaterialer.
DK105143C (da) Fremgangsmåde til tørring af tobak.
DK120752B (da) Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-4-oxider.
DK110208C (da) Fremgangsmåde til fremstilling af influenza-vacciner.
DK108227C (da) Fremgangsmåde til fremstilling af 3-carbonhydridoxy-17α-halogenethinyl-19-nor-3,5-androstadien-17β-oler.
DK132447B (da) Fremgangsmåde til fremstilling af kalvediarrevirusvaccine.
DK124340B (da) Fremgangsmåde til fremstilling af stærk svækket, levende Newcastle-syge-virus-vaccine.
DK116056B (da) Fremgangsmåde til fremstilling af 13-alkyl-gona-4,9-dien-3-oner eller deres D-homo-analoge.
DK113866B (da) Fremgangsmåde til fremstilling af somatiske antigenvacciner.
DK124753B (da) Analogifremgangsmåde til fremstilling af 13-alkyl-gonen-3,17-dioler.
DK102929C (da) Fremgangsmåde til sterilisering af vandige kompositioner.
DK119938B (da) Fremgangsmåde til fremstilling af mæslingevaccine.
DK102483C (da) Fremgangsmåde til fremstilling af en inaktiveret mund- og klovsygevaccine.
DK103021C (da) Fremgangsmåde til rensning af ɛ-caprolactam.
DK105983C (da) Fremgangsmåde til fremstilling af 2-alkoxy-5-aryl-3H-1,4-benzodiazepin-4-oxider.
DK100701C (da) Fremgangsmåde til fremstilling af en blandingsvaccine.
DK97204C (da) Fremgangsmåde til præservering af poliomyelitis-vaccine.
DK121297B (da) Fremgangsmåde til fremstilling af 19-hydroxyandrost-4-en-3,17-dion.
DK96738C (da) Fremgangsmåde til fremstilling af 3α-acyloxy-11-oxo-20,20-bis-(hydroxymethyl)-21-hydroxy-5β-pregnaner.
DK115706B (da) Fremgangsmåde til fremstilling af den L-isomere af α-methyl-3,4-dihydroxyphenylalanin.
DK98328C (da) Fremgangsmåde til fremstilling af 3α-acyloxy-11-oxo-20,20-bis-phosphatomethyl-21-hydroxy-5β-pregnaner.
DK99508C (da) Fremgangsmåde til fremstilling af 7-halogen-2-dimethylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxider.